查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1600563

CRISPR 技術市場：按產品、應用和最終用戶分類 - 2025-2030 年全球預測

CRISPR Technology Market by Offering (Product, Services), Application (Agricultural, Biomedical, Industrial), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年CRISPR技術市值為32.5億美元，預計到2024年將達到37.7億美元，複合年成長率為16.52%，到2030年將達到94.9億美元。

CRISPR 技術是基因編輯的突破性工具，透過精確修改 DNA，徹底改變了遺傳學和生物技術領域。其應用範圍廣泛，包括用於治療遺傳疾病的基因編輯、透過修改作物基因組來實現農業進步以及用於研究目的的基因改造模型的開發。對未滿足的關鍵字的需求是由它們解決未滿足的醫療需求、提高農業生產力和促進科學研究的潛力所驅動的。最終用途領域包括醫療保健、農業和生物技術產業，每個產業都利用該技術來增強產品供應和創新。

主要市場統計
基準年[2023] 32.5億美元
預測年份 [2024] 37.7億美元
預測年份 [2030] 94.9億美元
複合年成長率（%） 16.52%

市場成長受到需要新治療方法的遺傳疾病日益流行、確保糧食安全的農業生物技術進步以及公共和私營實體對研發的大量投資的影響。將 CRISPR 的應用範圍從治療和農業擴展到生質燃料生產和環境管理等領域，可以創造潛在的商機。為了利用這些機會，公司應該專注於策略夥伴關係和協作研究，將人工智慧靈活地整合到基因組學中進行精確編輯，以及開發強大的基因治療傳遞系統。

然而，市場面臨挑戰，包括倫理和安全問題、嚴格的法律規範以及與 CRISPR 專利相關的智慧財產權的複雜性。克服這些挑戰需要相關人員的全面參與來解決道德問題，有效地引導監管途徑，並建立強而有力的智慧財產權管理策略。還有一些成熟的創新和探索領域，例如提高 CRISPR 的特異性和效率、開發新的遞送機制以及探索研究較少或罕見遺傳疾病的治療應用。整體而言，市場動態是動態的，對於那些由創新驅動、能夠駕馭監管環境、在突破技術界限的同時有效解決道德問題的公司來說，存在著巨大的機會。

市場動態：揭示快速發展的 CRISPR 技術市場的關鍵市場洞察

供需的動態交互作用正在改變 CRISPR 技術市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 對遺傳疾病新疫苗和治療方法的需求不斷成長
    • 增加對生物技術和製藥領域的私人和公共投資
  • 市場限制因素
    • 由於政府法規，高成本且複雜
  • 市場機會
    • CRISPR技術的進步與改進
    • 在農業領域使用 CRISPR 技術的可能性
  • 市場挑戰
    • CRISPR 技術的技術挑戰與倫理議題

波特五力：駕馭 CRISPR 技術市場的策略工具

波特五力框架是了解 CRISPR 技術市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解 CRISPR 技術市場的外部影響

外部宏觀環境因素在塑造 CRISPR 技術市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解 CRISPR 技術市場的競爭格局

對 CRISPR 技術市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣 CRISPR 技術市場供應商績效評估

FPNV定位矩陣是評估CRISPR技術市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。四個象限清楚且準確地分類供應商，幫助使用者辨識最能滿足其策略目標的合作夥伴和解決方案。

本報告提供了涵蓋關鍵重點領域的全面市場分析：

1. 市場滲透率：對當前市場環境的詳細回顧，包括行業主要企業的大量資料。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 對遺傳疾病新疫苗和治療方法的需求增加
      • 增加對生物技術和製藥領域的私人和公共投資
    • 抑制因素
      • 與政府監管相關的高成本和複雜性
    • 機會
      • CRISPR技術的進步與改進
      • CRISPR技術在農業領域的潛在應用
    • 任務
      • 與 CRISPR 技術相關的技術挑戰和倫理問題
  • 市場區隔分析
    • 我們提供什麼：由於研究活動的激增和產品的改進，CRISPR套件和試劑的使用不斷增加。
    • 應用：擴大 CRISPR 技術在農業領域的應用
    • 最終用戶：CRISPR技術在生技公司的潛在應用
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境
  • 客戶客製化
    • CRISPR 正成為生質能源生產的可行解決方案
    • 擴大 CRISPR 技術的專利版圖

第6章 CRISPR 技術市場：透過提供

  • 產品
    • 酵素
    • 引導RNA
    • 試劑套件和試劑
  • 服務
    • 細胞株工程
    • gRNA 設計與載體構建
    • 篩檢服務

第7章 CRISPR 技術市場：依應用分類

  • 農業
  • 生物醫學
  • 產業

第 8 章 CRISPR 技術市場：按最終用戶分類

  • 學術和政府研究機構
  • 生技公司
    • 農業企業
    • 製藥公司

第9章 美洲CRISPR技術市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章 亞太地區CRISPR技術市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲的CRISPR技術市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • RoslinCT 開發基於 CRISPR 的治療方法
    • 第一種人類 CRISPR 藥物取得進展
    • ERS Genomics Limited (ERS) 與 Syngene International 簽署許可協議
    • Revvity (RVTY) 推出新服務以擴大編輯技術的使用範圍
    • Pencil Biosciences 融資 560 萬英鎊，用於推進罕見疾病的基因編輯
    • 整合式 DNA Technologies 與 Aldevron 結成策略聯盟，為細胞和基因治療開發商提供關鍵 CRISPR 組件
    • Bedoukian Research Inc. 與 Inscripta 合作，永續開發和生產天然成分。
    • Scribe 宣布合作加速基於 CRISPR 的體內基因藥物的開發
    • Vertex 表示計劃在 FDA 做出決定之前推出首個 Crispr 基因編輯療法
    • Sherlock Biosciences 收購 Sense Biodetection
    • Intellia Therapeutics 宣布收購 Relight Therapeutics

公司名單

  • Agilent Technologies, Inc.
  • Applied StemCell, Inc.
  • Beam Therapeutics Inc.
  • Caribou Biosciences, Inc.
  • Cellectis SA
  • CRISPR Therapeutics AG
  • Danaher Corporation
  • Editas Medicine, Inc.
  • ERS Genomics Limited
  • Function Oncology
  • GeneCopoeia, Inc.
  • GenScript Biotech Corporation
  • Horizon Discovery Group Ltd. by Revvity, Inc.
  • Inscripta, Inc.
  • Intellia Therapeutics, Inc.
  • Lonza Group Ltd.
  • Mammoth Biosciences, Inc.
  • Merck KGaA
  • New England Biolabs, Inc.
  • OriGene Technologies, Inc.
  • Prime Medicine, Inc.
  • Scribe Therapeutics
  • Sherlock Biosciences, Inc.
  • Synthego Corporation
  • Takara Holdings Inc.
  • Thermo Fisher Scientific Inc.
  • ToolGen, Inc.
  • TriLink BioTechnologies by Maravai Intermediate Holdings, LLC
  • Twist Bioscience Corporation
  • Verve Therapeutics, Inc.
Product Code: MRR-B1685377A648

The CRISPR Technology Market was valued at USD 3.25 billion in 2023, expected to reach USD 3.77 billion in 2024, and is projected to grow at a CAGR of 16.52%, to USD 9.49 billion by 2030.

CRISPR technology, a groundbreaking tool for gene editing, has revolutionized the fields of genetics and biotechnology by allowing precise modifications to DNA. Its scope encompasses a vast range of applications including therapeutic gene editing for genetic disorders, agricultural advancements through crop genome modification, and the development of genetically engineered models for research purposes. The necessity for CRISPR technology is driven by its potential to address unmet medical needs, improve agricultural productivity, and facilitate scientific research. End-use sectors include healthcare, agriculture, and biotechnology industries, each leveraging the technology to enhance product offerings and innovations.

KEY MARKET STATISTICS
Base Year [2023] USD 3.25 billion
Estimated Year [2024] USD 3.77 billion
Forecast Year [2030] USD 9.49 billion
CAGR (%) 16.52%

Market growth is influenced by the increasing prevalence of genetic disorders that necessitate novel therapeutic approaches, advancements in agricultural biotechnology to ensure food security, and substantial investments in R&D from both public and private entities. Potential opportunities lie in expanding CRISPR applications beyond therapeutics and agriculture into areas like biofuel production and environmental management. To capitalize on these opportunities, companies should focus on strategic partnerships and collaborations, agile integration of AI in genomics for precision editing, and development of robust delivery systems for gene therapies.

However, the market faces challenges such as ethical and safety concerns, stringent regulatory frameworks, and the complex nature of intellectual property rights pertaining to CRISPR patents. Overcoming these challenges requires comprehensive stakeholder engagement to address ethical issues, navigating regulatory pathways efficiently, and establishing strong IP management strategies. Areas of innovation and research ripe for exploration include enhancing CRISPR specificity and efficiency, developing novel delivery mechanisms, and exploring therapeutic applications in less-studied or rare genetic conditions. Overall, the CRISPR technology market is dynamic, driven by innovation, with substantial opportunities for businesses that can navigate the regulatory landscape and address ethical considerations effectively while pushing forward technological boundaries.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving CRISPR Technology Market

The CRISPR Technology Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing need for new vaccines and treatments for genetic diseases
    • Increasing private and public investments in biotechnological and pharmaceutical sectors
  • Market Restraints
    • High cost and complexities involved in the government regulations
  • Market Opportunities
    • Advancements and improvements in CRISPR technology
    • Potential use of CRISPR technology in the agriculture sector
  • Market Challenges
    • Technical challenges and ethical concerns associated with CRISPR technology

Porter's Five Forces: A Strategic Tool for Navigating the CRISPR Technology Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the CRISPR Technology Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the CRISPR Technology Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the CRISPR Technology Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the CRISPR Technology Market

A detailed market share analysis in the CRISPR Technology Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the CRISPR Technology Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the CRISPR Technology Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the CRISPR Technology Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Applied StemCell, Inc., Beam Therapeutics Inc., Caribou Biosciences, Inc., Cellectis S.A., CRISPR Therapeutics AG, Danaher Corporation, Editas Medicine, Inc., ERS Genomics Limited, Function Oncology, GeneCopoeia, Inc., GenScript Biotech Corporation, Horizon Discovery Group Ltd. by Revvity, Inc., Inscripta, Inc., Intellia Therapeutics, Inc., Lonza Group Ltd., Mammoth Biosciences, Inc., Merck KGaA, New England Biolabs, Inc., OriGene Technologies, Inc., Prime Medicine, Inc., Scribe Therapeutics, Sherlock Biosciences, Inc., Synthego Corporation, Takara Holdings Inc., Thermo Fisher Scientific Inc., ToolGen, Inc., TriLink BioTechnologies by Maravai Intermediate Holdings, LLC, Twist Bioscience Corporation, and Verve Therapeutics, Inc..

Market Segmentation & Coverage

This research report categorizes the CRISPR Technology Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Offering, market is studied across Product and Services. The Product is further studied across Enzymes, Guide RNA, and Kits & Reagents. The Services is further studied across Cell Line Engineering, gRNA Design & Vector Construction, and Screening Services.
  • Based on Application, market is studied across Agricultural, Biomedical, and Industrial.
  • Based on End User, market is studied across Academics & Government Research Institutes and Biotechnology Companies. The Biotechnology Companies is further studied across Agricultural Companies and Pharmaceutical Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Georgia, Illinois, Kentucky, Michigan, Mississippi, New Jersey, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing need for new vaccines and treatments for genetic diseases
      • 5.1.1.2. Increasing private and public investments in biotechnological and pharmaceutical sectors
    • 5.1.2. Restraints
      • 5.1.2.1. High cost and complexities involved in the government regulations
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements and improvements in CRISPR technology
      • 5.1.3.2. Potential use of CRISPR technology in the agriculture sector
    • 5.1.4. Challenges
      • 5.1.4.1. Technical challenges and ethical concerns associated with CRISPR technology
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Offering: Increasing use of CRISPR kits & reagents with the surging research activities and product improvements
    • 5.2.2. Application: Proliferating use of CRISPR technology in the agricultural sector
    • 5.2.3. End-User: Potential application of CRISPR technology in biotechnology companies
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental
  • 5.5. Client Customization
    • 5.5.1. CRISPR becoming a viable solution for bioenergy production
    • 5.5.2. Expanding patent landscape for CRISPR technology

6. CRISPR Technology Market, by Offering

  • 6.1. Introduction
  • 6.2. Product
    • 6.2.1. Enzymes
    • 6.2.2. Guide RNA
    • 6.2.3. Kits & Reagents
  • 6.3. Services
    • 6.3.1. Cell Line Engineering
    • 6.3.2. gRNA Design & Vector Construction
    • 6.3.3. Screening Services

7. CRISPR Technology Market, by Application

  • 7.1. Introduction
  • 7.2. Agricultural
  • 7.3. Biomedical
  • 7.4. Industrial

8. CRISPR Technology Market, by End User

  • 8.1. Introduction
  • 8.2. Academics & Government Research Institutes
  • 8.3. Biotechnology Companies
    • 8.3.1. Agricultural Companies
    • 8.3.2. Pharmaceutical Companies

9. Americas CRISPR Technology Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific CRISPR Technology Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa CRISPR Technology Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. RoslinCT Manufacture CRISPR-Based Therapy
    • 12.3.2. First Human CRISPR Drug Moves Forward
    • 12.3.3. ERS Genomics Limited ('ERS') Completes Licensing Agreement With Syngene International
    • 12.3.4. Revvity's (RVTY) New Launch to Widen Access to Editing Technology
    • 12.3.5. Pencil Biosciences Raises GBP 5.6 Million to Advance Gene Editing for Rare Diseases
    • 12.3.6. Integrated DNA Technologies and Aldevron Activate Strategic Partnership to Deliver Key CRISPR Components to Cell and Gene Therapy Developers
    • 12.3.7. Bedoukian Research Inc. Partners with Inscripta to Sustainably Develop and Manufacture Naturally Produced Ingredients
    • 12.3.8. Scribe Announces Collaboration to Accelerate In Vivo CRISPR-Based Genetic Medicines
    • 12.3.9. Vertex Teases Launch Plans for First Crispr Gene Editing Therapy Ahead of FDA Decision
    • 12.3.10. Sherlock Biosciences to Acquire Sense Biodetection
    • 12.3.11. Intellia Therapeutics Announces Acquisition of Rewrite Therapeutics

Companies Mentioned

  • 1. Agilent Technologies, Inc.
  • 2. Applied StemCell, Inc.
  • 3. Beam Therapeutics Inc.
  • 4. Caribou Biosciences, Inc.
  • 5. Cellectis S.A.
  • 6. CRISPR Therapeutics AG
  • 7. Danaher Corporation
  • 8. Editas Medicine, Inc.
  • 9. ERS Genomics Limited
  • 10. Function Oncology
  • 11. GeneCopoeia, Inc.
  • 12. GenScript Biotech Corporation
  • 13. Horizon Discovery Group Ltd. by Revvity, Inc.
  • 14. Inscripta, Inc.
  • 15. Intellia Therapeutics, Inc.
  • 16. Lonza Group Ltd.
  • 17. Mammoth Biosciences, Inc.
  • 18. Merck KGaA
  • 19. New England Biolabs, Inc.
  • 20. OriGene Technologies, Inc.
  • 21. Prime Medicine, Inc.
  • 22. Scribe Therapeutics
  • 23. Sherlock Biosciences, Inc.
  • 24. Synthego Corporation
  • 25. Takara Holdings Inc.
  • 26. Thermo Fisher Scientific Inc.
  • 27. ToolGen, Inc.
  • 28. TriLink BioTechnologies by Maravai Intermediate Holdings, LLC
  • 29. Twist Bioscience Corporation
  • 30. Verve Therapeutics, Inc.

LIST OF FIGURES

  • FIGURE 1. CRISPR TECHNOLOGY MARKET RESEARCH PROCESS
  • FIGURE 2. CRISPR TECHNOLOGY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS CRISPR TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS CRISPR TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES CRISPR TECHNOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES CRISPR TECHNOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. CRISPR TECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. CRISPR TECHNOLOGY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CRISPR TECHNOLOGY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CRISPR TECHNOLOGY MARKET DYNAMICS
  • TABLE 7. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY ENZYMES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY GUIDE RNA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY CELL LINE ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY GRNA DESIGN & VECTOR CONSTRUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY SCREENING SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY AGRICULTURAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY BIOMEDICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY INDUSTRIAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY ACADEMICS & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY AGRICULTURAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS CRISPR TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES CRISPR TECHNOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 73. AUSTRALIA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 74. AUSTRALIA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 79. CHINA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 80. CHINA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. CHINA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 84. CHINA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 85. INDIA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 86. INDIA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. INDIA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 88. INDIA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. INDIA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 91. INDONESIA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 92. INDONESIA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. INDONESIA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 94. INDONESIA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. INDONESIA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. INDONESIA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 97. JAPAN CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 98. JAPAN CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. JAPAN CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 100. JAPAN CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. JAPAN CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. JAPAN CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 103. MALAYSIA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 104. MALAYSIA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. MALAYSIA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 106. MALAYSIA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. MALAYSIA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 108. MALAYSIA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 109. PHILIPPINES CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 110. PHILIPPINES CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. PHILIPPINES CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 112. PHILIPPINES CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 114. PHILIPPINES CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 115. SINGAPORE CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 116. SINGAPORE CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. SINGAPORE CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 118. SINGAPORE CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. SINGAPORE CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 120. SINGAPORE CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 121. SOUTH KOREA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 122. SOUTH KOREA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH KOREA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH KOREA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH KOREA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 127. TAIWAN CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 128. TAIWAN CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. TAIWAN CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 130. TAIWAN CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. TAIWAN CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. TAIWAN CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 133. THAILAND CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 134. THAILAND CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. THAILAND CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 136. THAILAND CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. THAILAND CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. THAILAND CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 139. VIETNAM CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 140. VIETNAM CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. VIETNAM CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 142. VIETNAM CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. VIETNAM CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 144. VIETNAM CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 152. DENMARK CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 153. DENMARK CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 154. DENMARK CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 155. DENMARK CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. DENMARK CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 157. DENMARK CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 158. EGYPT CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 159. EGYPT CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 160. EGYPT CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 161. EGYPT CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. EGYPT CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 163. EGYPT CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 164. FINLAND CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 165. FINLAND CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 166. FINLAND CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 167. FINLAND CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. FINLAND CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 169. FINLAND CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 170. FRANCE CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 171. FRANCE CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. FRANCE CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 173. FRANCE CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. FRANCE CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 175. FRANCE CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 176. GERMANY CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 177. GERMANY CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. GERMANY CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 179. GERMANY CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. GERMANY CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 181. GERMANY CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 182. ISRAEL CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 183. ISRAEL CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 184. ISRAEL CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 185. ISRAEL CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. ISRAEL CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 187. ISRAEL CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 188. ITALY CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 189. ITALY CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 190. ITALY CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 191. ITALY CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. ITALY CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 193. ITALY CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 194. NETHERLANDS CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 195. NETHERLANDS CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 196. NETHERLANDS CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 197. NETHERLANDS CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 198. NETHERLANDS CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 200. NIGERIA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 201. NIGERIA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 202. NIGERIA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 203. NIGERIA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 204. NIGERIA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 205. NIGERIA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 206. NORWAY CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 207. NORWAY CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 208. NORWAY CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 209. NORWAY CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 210. NORWAY CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 211. NORWAY CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 212. POLAND CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 213. POLAND CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 214. POLAND CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 215. POLAND CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 216. POLAND CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 217. POLAND CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 218. QATAR CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 219. QATAR CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 220. QATAR CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 221. QATAR CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 222. QATAR CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 223. QATAR CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 224. RUSSIA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 225. RUSSIA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 226. RUSSIA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 227. RUSSIA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 228. RUSSIA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 229. RUSSIA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 230. SAUDI ARABIA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 231. SAUDI ARABIA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 232. SAUDI ARABIA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 234. SAUDI ARABIA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 236. SOUTH AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 237. SOUTH AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 238. SOUTH AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 242. SPAIN CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 243. SPAIN CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 244. SPAIN CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 245. SPAIN CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 246. SPAIN CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 247. SPAIN CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 248. SWEDEN CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 249. SWEDEN CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 250. SWEDEN CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 251. SWEDEN CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 252. SWEDEN CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 253. SWEDEN CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 254. SWITZERLAND CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 255. SWITZERLAND CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 256. SWITZERLAND CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 258. SWITZERLAND CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 260. TURKEY CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 261. TURKEY CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 262. TURKEY CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 263. TURKEY CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 264. TURKEY CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 265. TURKEY CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 266. UNITED ARAB EMIRATES CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 267. UNITED ARAB EMIRATES CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 268. UNITED ARAB EMIRATES CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 269. UNITED ARAB EMIRATES CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED KINGDOM CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED KINGDOM CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED KINGDOM CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED KINGDOM CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 278. CRISPR TECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 279. CRISPR TECHNOLOGY MARKET, FPNV POSITIONING MATRIX, 2023